Literature DB >> 10652674

The Duett closure device: concept and experimental results.

G Gershony1, T Jensen.   

Abstract

Purpose of this paper is to investigate the hemostatic capabilities of a novel vascular sealing device consisting of a balloon catheter and procoagulant. Vascular sheaths were placed percutaneously in the femoral arteries of dogs. The sealing device was evaluated using the balloon catheter alone in 6 femoral arteries and with the addition of a procoagulant in 21 femoral arteries. The balloon catheter alone was successfully deployed in 6 of 6 femoral arteries achieving immediate hemostasis. In a second study in which the procoagulant was delivered following balloon placement, the sealing device was successfully deployed and hemostasis was achieved in 20 of 21 attempts (95%) despite removal of the balloon catheter. In a subset of fully anticoagulated animals, hemostasis was achieved in the sealing device-treated arteries at 6.5 +/- 3.4 minutes but in none of the controls (p < 0.001). This novel vascular sealing device successfully achieves rapid hemostasis in normal and anticoagulated dogs following percutaneous vascular procedures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10652674     DOI: 10.1007/bf03044485

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  22 in total

Review 1.  Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: analysis of 6007 published patients.

Authors:  S Silber
Journal:  Am Heart J       Date:  1998-01       Impact factor: 4.749

2.  Has the time come for the plug?

Authors:  J Vainer; B Meier
Journal:  Cathet Cardiovasc Diagn       Date:  1996-04

3.  Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty.

Authors:  S W Oweida; G S Roubin; R B Smith; A A Salam
Journal:  J Vasc Surg       Date:  1990-09       Impact factor: 4.268

4.  Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device.

Authors:  W G Kussmaul; M Buchbinder; P L Whitlow; U T Aker; R R Heuser; S B King; K M Kent; M B Leon; D M Kolansky; J G Sandza
Journal:  J Am Coll Cardiol       Date:  1995-06       Impact factor: 24.094

5.  Predictors of groin complications after balloon and new-device coronary intervention.

Authors:  R Waksman; S B King; J S Douglas; Y Shen; H Ewing; L Mueller; Z M Ghazzal; W S Weintraub
Journal:  Am J Cardiol       Date:  1995-05-01       Impact factor: 2.778

6.  Vascular complications after balloon and new device angioplasty.

Authors:  J J Popma; L F Satler; A D Pichard; K M Kent; A Campbell; Y C Chuang; C Clark; A J Merritt; T A Bucher; M B Leon
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

7.  In-hospital costs associated with new percutaneous coronary devices.

Authors:  R J Dick; J J Popma; D W Muller; K A Burek; E J Topol
Journal:  Am J Cardiol       Date:  1991-10-01       Impact factor: 2.778

8.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.

Authors:  D L Fischman; M B Leon; D S Baim; R A Schatz; M P Savage; I Penn; K Detre; L Veltri; D Ricci; M Nobuyoshi
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

9.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Authors: 
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

10.  Current complications of diagnostic and therapeutic cardiac catheterization.

Authors:  R M Wyman; R D Safian; V Portway; J J Skillman; R G McKay; D S Baim
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.